NOVO NORDISK – Ozempic (Semaglutide) – 4 mg Pen
Each Ozempic pre-filled pen contains:
Total Content: 4 mg of Semaglutide.
Dosing Options: Delivers doses of 0.25 mg, 0.5 mg, or 1 mg per injection, as prescribed by a healthcare provider.
Indications:
Ozempic is indicated for adults with type 2 diabetes to improve blood sugar control when combined with diet and exercise. It may also aid in weight management as part of a comprehensive diabetes care plan.
Administration:
Administered once weekly by subcutaneous injection, typically in the abdomen, thigh, or upper arm. The starting dose is often 0.25 mg weekly for the first four weeks, followed by an increase to 0.5 mg or 1 mg based on individual response and medical guidance.
Effects:
Ozempic is a GLP-1 receptor agonist that enhances insulin secretion, decreases glucagon release, and slows gastric emptying. This mechanism supports stable blood glucose control and may help reduce appetite, contributing to potential weight management benefits.
Side Effects:
Common side effects include nausea, vomiting, and appetite reduction. Rare but serious side effects can include pancreatitis, kidney issues, and potential thyroid tumors.
Contraindications:
Not suitable for those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or certain gastrointestinal disorders. Regular monitoring of blood glucose and health status is recommended to ensure safe and effective use.
